Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

Current Medical Research and Opinion

Volumn 24, Issue 4, 2008, Pages 1033-1038

  Hernández, Carlos ^a   Estivill, Eduard ^b   Prieto, Marta ^c   Badía, Xavier ^d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUT UNIVERSITARI DEXEUS   (Spain)

^c Astellas Pharma   (Spain)

^d IQVIA   (United States)

Author keywords

Benign prostatic hyperplasia; Epidemiological study; Lower urinary tract symptoms; Nocturia; Quality of life; Spain

Indexed keywords

AGED; ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; NOCTURIA; OUTPATIENT CARE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; QUESTIONNAIRE; SPAIN; STATISTICAL SIGNIFICANCE;

AGED; CROSS-SECTIONAL STUDIES; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NOCTURIA; PREVALENCE; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SPAIN;

EID: 42549161182     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079908X280473     Document Type: Article

References (27)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-78
2. van Kerrebroeck P, Abrams P, Chaikin D, et al. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int 2002;90(Suppl 3):11-5
3. Chasens ER, Umlauf MG. Nocturia: a problem that disrupts sleep and predicts obstructive sleep apnea. Geriatr Nurs 2003;24:76-81
4. Jolleys JV, Donovan JL, Nanchahal K, et al. Urinary symptoms in the community: how bothersome are they? Br J Urol 1994;74:551-5
5. Schatzl G, Temml C, Schmidbauer J, et al. Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project. Urology 2000;56:71-5
6. Tikkinen KA, Tammela TL, Huhtala H, Auvinen A. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006;175:596-600
7. van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int 2002;90:644-8
8. Abrams P. Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO). Eur Urol Suppl 2005;3:8-16
9. Eckhardt MD, van Venrooij GE, Boon TA. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology 2001;57:695-700
10. Yoshimura K, Ohara H, Ichioka K, et al. Nocturia and benign prostatic hyperplasia. Urology 2003;61:786-90
11. Abrams P. Nocturia: the effect on sleep and related health consequences. Eur Urol Suppl 2005;3:1-7
12. Peters TJ, Donovan JL, Kay HE, et al. The International Continence Society 'Benign Prostatic Hyperplasia' Study: the bothersomeness of urinary symptoms. J Urol 1997;157:885-9
13. Bing MH, Moller LA, Jennum P, et al. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60-80 years. BJU Int 2006;98:599-604
14. Asplund R. Nocturia: consequences for sleep and daytime activities and associated risks. Eur Urol Suppl 2005;3:24-32
15. Schneider T, Stanley N. Impact of nocturia on sleep and energy. Eur Urol Supplements 2007;6:585-93
16. Barry MJ, Fowler FJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57
17. Abraham L, Hareendran A, Mills IW, et al. Development and validation of a quality-of-life measure for men with nocturia. Urology 2004;63:481-6
18. Badia X, Garcia-Losa M, Dal-Re R. Ten-language translation and harmonization of the International Prostate Symptom Score: developing a methodology for multinational clinical trials. Eur Urol 1997;31:129-40
19. Badia X, Garcia-Losa M, Dal-Re R, et al. Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symptom Score. Urology 1998;52:614-20
20. Eckhardt MD, van Venrooij GE, van Melick HH, Boon TA. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 2001;166:563-8
21. Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993;150:85-9
22. Yu HJ, Chen FY, Huang PC, et al. Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older. Urology 2006;67:713-8
23. Kobelt G, Borgstrom F, Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int 2003;91:190-5
24. van Dijk L, Kooij DG, Schellevis FG, et al. Nocturia: impact on quality of life in a Dutch adult population. BJU Int 2004;93:1001-4
25. Asplund R, Aberg H. Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care 1992;10:98-104
26. Yoshimura K, Terada N, Matsui Y, et al. Prevalence of and risk factors for nocturia: analysis of a health screening program. Int J Urol 2004;11:282-7
27. Bankir L, Bardoux P, Ahloulay M. Vasopressin and diabetes mellitus. Nephron 2001;87:8-18